Informa to sell Pharma Intelligence for £1.9bn to Warburg Pincus

International B2B and business intelligence group Informa has announced the sale of its Pharma Intelligence operation to private equity firm Warburg Pincus for a fee totalling £1.9bn.

By Press Association and Press Gazette

International B2B and business intelligence group Informa has announced the sale of its Pharma Intelligence operation to private equity firm Warburg Pincus for a fee totalling £1.9bn.

A leading provider of specialist intelligence and data for clinical trials, drug development and regulatory compliance, Pharma Intelligence accounted for 40% of the £305m revenues reported for the company’s Informa Intelligence division in 2020.

Informa will retain a 15% stake in the business going forward and has also announced plans for a new round of share buybacks.

Source: Informa

Deal value: £1.9bn

Select and enter your email address

Future of Media

Weekly insight into the big strategic issues affecting the future of the news industry. Essential reading for media leaders every Thursday.

Press Gazette Daily

Your morning brew of news about the world of news from Press Gazette and elsewhere in the media. Sent at around 10am UK time.

Future Of Media USA

Our weekly does of strategic insight about the future of news media aimed at US readers.

Marketing Matters

A fortnightly update from the front-line of news and advertising. Aimed at marketers and those involved in the advertising industry.

Your email address

Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Thanks for subscribing.

Country: UK